Similar to CHK1 inhibition, recent studies showed that the pharmacological inhibition of ATR may induce cGAS-STING-mediated anti-tumor immunity and may trigger tumors for immune checkpoint blockade [150,151]. Here, CHEK1 is linked to neoplasm.